Effect of diabetes of the formation of the active sulphate carrier phosphoadenosine-phosphosulphate (PAPS) by rat liver soluble enzyme.
D000227:Adenine Nucleotides / Q000096:biosynthesis*; D000249:Adenosine Monophosphate / Q000096:biosynthesis; D000818:Animals; D002807:Chondroitin / Q000096:biosynthesis; D002854:Chromatography, Paper; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000201:enzymology*; D004798:Enzymes / Q000008:administration & dosage / Q000494:pharmacology; D008099:Liver / Q000201:enzymology*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010179:Pancreas / Q000502:physiology; D010180:Pancreatectomy; D010756:Phosphoric Acids / Q000096:biosynthesis; D051381:Rats; D012995:Solubility; D013268:Stimulation, Chemical; D013431:Sulfates / Q000378:metabolism; D013460:Sulfur Isotopes; D013464:Sulfuric Acids / Q000096:biosynthesis* / Q000378:metabolism
D000227:Adenine Nucleotides; D004798:Enzymes; D010756:Phosphoric Acids; D013431:Sulfates; D013460:Sulfur Isotopes; D013464:Sulfuric Acids; D000249:Adenosine Monophosphate; D002807:Chondroitin